← BioTransfer GEO Dataset Finder
GEO series

Mirdametinib treatment for the osteofibrous dysplasia RASopathy

GSE305253 Homo sapiens Expression profiling by high throughput sequencing 24 samples 2026/02/11 GPL30173
Summary
The goal of this study was to investigate the molecular response of primary cells cultured from the pseudarthrosis sites of Osteofibrous Dysplasia patients following 24h treatment with vehicle (DMSO), capmatinib (10uM, Catalog# S2788, Selleck Chemicals, USA), selumetinib (5uM, Catalog# S1008, Selleck Chemicals, USA), or mirdametinib (100nM, Catalog# S1036, Selleck Chemicals, USA). Transcriptional changes were
Download
NCBI GEO page ↗ Paper (PMID 41746735) ↗ {# Names what the click gives you. "Open in finder" meant nothing to a visitor who arrived from a search engine and has never seen the tool. #} Find more human RNA-seq datasets →
Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.